
HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Analysts at HC Wainwright decreased their Q3 2027 earnings per share (EPS) estimates for shares of HIVE Blockchain Technologies in a research report issued on Wednesday, November 11th. HC Wainwright analyst M. Colonnese now forecasts that the company will earn ($0.21) per share for the quarter, down from their prior estimate of ($0.13). HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2027 earnings at ($0.16) EPS, Q1 2028 earnings at ($0.13) EPS, Q2 2028 earnings at ($0.11) EPS, Q3 2028 earnings at ($0.10) EPS, Q4 2028 earnings at ($0.11) EPS and FY2028 earnings at ($0.47) EPS.
Separately, Chardan Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Monday, July 27th. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, HIVE Blockchain Technologies has a consensus rating of “Buy”.
Get Our Latest Report on HIVE Blockchain Technologies
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Featured Articles
- Five stocks we like better than HIVE Blockchain Technologies
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
